A new National Institutes of Health grant supports the next phase of a national effort to use AI, brain imaging, genetics and data to better classify Alzheimer’s and related diseases, predict progression and identify new treatment targets.
A USC team has identified important differences in how early Alzheimer’s-related brain changes appear across racial and ethnic groups, underscoring the need for more inclusive approaches to studying and diagnosing the disease.
USC’s John Oghalai and Alberto Recio receive an American Hearing Research Foundation Discovery Grant.
USC scientists and artists — along with creative staff of The Pitt — shared groundbreaking interdisciplinary collaborations at the intersection of creativity and health care.
“This immediate impact on air pollution is really important because it also has an immediate impact on health,” said USC’s Erika Garcia, the study’s senior author.
A multidisciplinary team has developed a selective compound that inhibits an enzyme tied to inflammation in people at genetic risk for Alzheimer’s — while preserving normal brain function and crossing the blood-brain barrier.
A USC study finds that vaccination correlates with lower inflammation, slower epigenetic and transcriptomic aging, and slower overall biological aging in Americans age 70 and older.
The new research provides a blueprint for understanding memory and disease.
USC researchers studied the relationship between PFAS exposure and changes in markers of type 2 diabetes in teens who underwent the weight-reduction surgery.
USC researchers are launching a clinical trial examining whether specially bioengineered stem cells might restore eyesight.
